Specialty Pharmacy

Combination treatment prior to surgery changes the clinical significance of growth factors as potential biomarkers.

Prevention programs, HIV testing, and easier access to treatment are all areas that need to be addressed.

Fake hepatitis C pills are entering the distribution network through back-channel wholesalers.

Teva loses patent infringement litigations for Copaxone.

Top news of the day from across the health care landscape.

President Donald Trump signed an executive order this week that could have direct implications for the FDA.

Would federal funding cuts to the Ryan White Care Act be "devastating" to the HIV-positive population?

Incidence of sleep apnea is 75% higher in patients with rheumatoid arthritis.

Gene may induce a broad-spectrum cellular response against infectious diseases.

RG-101 placed on clinical hold last year after a second reported case of jaundice.

Top news of the day from across the health care landscape.

HIV non-disclosure not found to have an adverse impact on depression or anxiety symptoms.

Risk factor may serve as a future drug target for ulcerative colitis.

Availability of new therapies and cost concerns create barriers for cancer patients.

Daniel P. Kus, BS Pharm, RPh, discusses how specialty pharmacies can help patients manage out-of-pocket drug spending.

Findings may lead to increased survival in patients with glioblastoma.

PHLDB3 inhibits the p53 protein to promote tumor growth.

Study estimates 27% of men avoided an unnecessary biopsy for prostate cancer when given an MRI scan first.

Top news of the day from across the health care landscape.

Dalfampridine extended-release tablets deemed bioequivalent of Amprya.

Prime Aid alleges that Express Scripts removed the pharmacy from their network to steer customers towards Accredo.

Specialty pharmacy squares off with pharmacy benefit manager over contractual dispute.

PGAM1 inhibitors sensitize tumors to lynparza (Olaparib) treatment.

Statins degrade mutated p53 proteins, offering future cancer treatment.

Poor long-term survival rates for pediatric patients with acute megakaryoblastic leukemia.

New index more precisely determines the probability of reducing liver fat during lifestyle interventions.

The microbiome and inflammatory signature differs in patients with type 1 diabetes.

Top news of the day from across the health care landscape.